Skip to content
Board of Directors
Scientific Advisory Board
Conferences and Exhibitions
Cell Line Development
Cell Engineering and Synthetic Biology
Where to Buy
Service & Support
Sphere Fluidics’ Blogs
Why Make the Switch to Picodroplet-based Technologies for Antibody Discovery?
The benefits of switching to picodroplet-based technologies for antibody discovery.
The Sphere Fluidics' SAB: Insights from Dr Tristan Vaughan
Dr Tristan Vaughan shares his perspectives on biological medicines development, the potential for single cell analysis platforms in advancing the field.
Targeting Antigen Specificity: A Revolutionary Platform for Isolating Rare Cells
This blog discusses how the detection of rare cells from large populations by miniaturized immunoassays in picodroplets increases the speed and efficiency of selective cell screening and reduces screening costs.
Transforming Cell Line Development Processes
Dr Fay Saunders, UK Head of Upstream Mammalian Cell Culture, Process Development at FUJIFILM Diosynth Biotechnologies, shares her experience of using Cyto-Mine® in cell line development and recombinant protein expression.
Sorting with Cyto-Mine®
This article outlines some techniques and tips from our Senior Service Engineer, Darren Matthews, on optimizing PMT settings using Cyto-Mine®.
4 Best practices for optimizing Cell Line Development processes
Jon Dempsey, Pathway Biopharma, shares how companies can improve product quality and yields, as well as shorten overall cell line development timelines.
How can we speed up vaccine development for COVID-19?
Cyto-Mine® reduces the cell line development process by 3 months, enabling researchers to make a new vaccine much faster